Share this article
Download our case study to:
Learn how TFS successfully navigated a complex Phase I study aimed at evaluating a novel therapy with the potential to strengthen existing antibiotic treatments for highly contagious Mycobacterium tuberculosis (MTB).
Conducted in single-ascending and multiple-ascending dose portions, TFS faced challenges related to strict inclusion criteria, a high screen failure rate, and unforeseen disruptions like Brexit and the COVID-19 pandemic. Download our case study to discover the tactics deployed and the remarkable outcomes achieved in this groundbreaking research.